Save your place

Sign in to WhoBought

Please try again later.

Aldeyra Therapeutics, Inc. (ALDX) institutional ownership

Latest close $1.54 Jul 31, 2026
Market cap$288M 52-week range SectorHealthcare
Funds holding · Q1 2026
134
reported ALDX position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
67 buyers · 67 sellers

Aldeyra Therapeutics, Inc. (ALDX) price and institutional activity

Dates

Q1 2026

$0 bought by 67 investors
AQR Capital Management LLCMillennium Management LLC +65 more
$0 sold by 67 investors
Perceptive Advisors LLCKennedy Capital Management LLC +65 more
Bought Sold Totals per quarter; hover a bar for the names.

Aldeyra Therapeutics, Inc. (ALDX) institutional activity · 134

Investor Type Est. change Change Δ Own Date
Perceptive Advisors LLC · Exited
Change −4.2M Δ Own −100.0% Date Q1 2026
Perceptive Advisors LLC Exited· Q1 2026 −4.2M −100.0% Q1 2026
AQR Capital Management LLC · Added
Change +1.6M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +1.6M Q1 2026
Kennedy Capital Management LLC · Reduced
Change −1.2M Date Q1 2026
Kennedy Capital Management LLC Reduced· Q1 2026 −1.2M Q1 2026
Millennium Management LLC · Added
Change +951K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +951K Q1 2026
Propel Bio Management, LLC · New
Change +731K Date Q1 2026
Propel Bio Management, LLC New· Q1 2026 +731K Q1 2026
Jane Street Group, LLC · Added
Change +665K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +665K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +513K +146.6% Q1 2026
Ardsley Advisory Partners LP · Reduced
Change −500K Date Q1 2026
Ardsley Advisory Partners LP Reduced· Q1 2026 −500K Q1 2026
UBS Group AG · Added
Change +442K Date Q1 2026
UBS Group AG Added· Q1 2026 +442K Q1 2026
Kingdon Capital Management, L.L.C. · Added
Change +302K Date Q1 2026
Kingdon Capital Management, L.L.C. Added· Q1 2026 +302K Q1 2026
Hrt Financial LP · New
Change +286K Date Q1 2026
Hrt Financial LP New· Q1 2026 +286K Q1 2026
Deutsche Bank AG · Reduced
Change −267K Date Q1 2026
Deutsche Bank AG Reduced· Q1 2026 −267K Q1 2026
Citadel Advisors LLC New· Q1 2026 +266K Q1 2026
Goldman Sachs Group Inc · Added
Change +237K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +237K Q1 2026
BNP Paribas Financial Markets · Reduced
Change −234K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −234K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 134

Famous investor activity in Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics, Inc. (ALDX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Miller-Rich Nancy · Director 2 operations 73K
Owned 3K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Miller-Rich Nancy Director 2 operations 73K 3K Jun 9, 2026 Jun 11, 2026
Douglas Richard · Director 3 operations 92K
Owned 2K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Douglas Richard Director 3 operations 92K 2K Jun 9, 2026 Jun 11, 2026
Phillips Gary M. · Director 3 operations 82K
Owned 5K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Phillips Gary M. Director 3 operations 82K 5K Jun 9, 2026 Jun 11, 2026
Clark William D. · Director 2 operations 72K
Owned 2K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Clark William D. Director 2 operations 72K 2K Jun 9, 2026 Jun 11, 2026
Walker Neal · Director 2 operations 73K
Owned 3K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Walker Neal Director 2 operations 73K 3K Jun 9, 2026 Jun 11, 2026
Bronstein Ben · Director 3 operations 80K
Owned 5K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Bronstein Ben Director 3 operations 80K 5K Jun 9, 2026 Jun 11, 2026
Deptula-Hicks Darlene M. · Director 2 operations 94K
Owned 10K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Deptula-Hicks Darlene M. Director 2 operations 94K 10K Jun 9, 2026 Jun 11, 2026
Brady Todd C. · Director Buy +$418K
Price $1.67 Qty +250K Owned 1.7M Trade date Jun 3, 2026 Filed date Jun 5, 2026
Brady Todd C. Director Buy $1.67 +250K +$418K 1.7M Jun 3, 2026 Jun 5, 2026
Brady Todd C. · Director, Officer 2 operations 2.5M
Owned 632K Trade date Mar 27, 2026 Filed date Mar 31, 2026
Brady Todd C. Director, Officer 2 operations 2.5M 632K Mar 27, 2026 Mar 31, 2026
Douglas Richard · Director Buy +$98K
Price $1.40 Qty +70K Owned 195K Trade date Mar 19, 2026 Filed date Mar 20, 2026
Douglas Richard Director Buy $1.40 +70K +$98K 195K Mar 19, 2026 Mar 20, 2026
Alfieri Michael · Officer Buy +$7K
Price $1.42 Qty +5K Owned 8K Trade date Mar 18, 2026 Filed date Mar 19, 2026
Alfieri Michael Officer Buy $1.42 +5K +$7K 8K Mar 18, 2026 Mar 19, 2026
Alfieri Michael · Officer Buy +$13K
Price $5.30 Qty +2K Owned 2K Trade date Aug 13, 2025 Filed date Aug 15, 2025
Alfieri Michael Officer Buy $5.30 +2K +$13K 2K Aug 13, 2025 Aug 15, 2025
Machatha Stephen · Officer Sell −$114K
Price $5.15 Qty −22K Owned 222K Trade date Aug 11, 2025 Filed date Aug 13, 2025
Machatha Stephen Officer Sell $5.15 −22K −$114K 222K Aug 11, 2025 Aug 13, 2025
13 of 13

Aldeyra Therapeutics, Inc. (ALDX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Perceptive Advisors LLC 9.3M
% of shares outstanding 15.6% Filing date Nov 14, 2024
Perceptive Advisors LLC 9.3M 15.6% Nov 14, 2024
Vanguard Group Inc 3.9M
% of shares outstanding 6.7% Filing date Feb 13, 2024
Vanguard Group Inc 3.9M 6.7% Feb 13, 2024
Knoll Capital Management, LLC 3.6M
% of shares outstanding 6.1% Filing date Oct 4, 2023
Knoll Capital Management, LLC 3.6M 6.1% Oct 4, 2023
BlackRock Inc. 3.4M
% of shares outstanding 5.8% Filing date Jan 29, 2024
BlackRock Inc. 3.4M 5.8% Jan 29, 2024
Blackrock, Inc. 1.0M
% of shares outstanding 1.7% Filing date Jul 27, 2026
Blackrock, Inc. 1.0M 1.7% Jul 27, 2026
State Street Corp
% of shares outstanding 0.3% Filing date Feb 3, 2023
State Street Corp 0.3% Feb 3, 2023
Perceptive Advisors LLC 0
% of shares outstanding 0.0% Filing date May 15, 2026
Perceptive Advisors LLC 0 0.0% May 15, 2026
Vanguard Group Inc 0
% of shares outstanding 0.0% Filing date Mar 26, 2026
Vanguard Group Inc 0 0.0% Mar 26, 2026
8 of 8

Aldeyra Therapeutics, Inc. (ALDX) ownership FAQ

Who owns ALDX?

134 reporting institutions disclosed ALDX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.